Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison

Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endosc...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 12; no. 6; pp. 838 - 848
Main Authors Li, Wanpeng, Liu, Qiang, Wang, Huan, Zhang, Huangkang, Liu, Quan, Hu, Li, Li, Houyong, Dai, Jiong, Sun, Xicai, Yu, Hongmeng, Wang, Dehui
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The efficacy and safety of internal carotid artery (ICA) embolization as a treatment strategy in recurrent nasopharyngeal carcinoma (rNPC) patients with tumors invading the ICA remain unclear. Methods We enrolled all rNPC patients with tumors invading the ICA, who underwent salvage endoscopic surgery. Using propensity scores to adjust for specific potential prognostic factors, a well‐balanced cohort of 42 patients with limited rNPC was formed by matching each patient who underwent ICA embolization (study group) with one who did not (control group). The survival rates and common treatment‐related complications were compared between the 2 groups. Results The cohort included patients with the following tumor stages: rT2 (n = 3), rT3 (n = 24), and rT4 (n = 15). During a median follow‐up of 15 (range, 2‐63) months, the 2‐year overall survival and progression‐free survival rates were significantly higher in the ICA embolization group than in the ICA nonembolization group (90.5% vs 53.3% and 71.3% vs 33.0%, respectively; and p = 0.022 and p = 0.006, respectively). In addition, the incidence of treatment‐related complications, such as nasal obstruction, nasopharyngeal hemorrhage, and nasopharyngeal necrosis, was significantly lower in the ICA embolization group than in the nonembolization group (p = 0.001, p = 0.014, and p = 0.038, respectively). Conclusion The innovative application of ICA embolization in endoscopic surgery in patients with rNPC invading the ICA significantly improved patient survival and reduced the risk of treatment‐related complications. Therefore, this may be a safe and effective method with the potential to improve outcomes in rNPC patients.
Bibliography:Additional Supporting Information may be found in the online version of this article.
Wanpeng Li and Qiang Liu contributed equally to this work.
Potential conflict of interest: None provided.
View this article online at wileyonlinelibrary.com.
Funding sources for the study: National Natural Science Foundation of China (No. 81870703); Shanghai Shen Kang Hospital Development Center (SHDC12018118); Clinical Research Plan of the SHDC (SHDC2020CR2005A); Shanghai Science and Technology Committee Foundation (19411950600); New Technologies of Endoscopic Surgery in Skull Base Tumor, CAMS innovation Fund for Medical Sciences (2019‐12 M‐5‐003); Science and Technology Commission of Shanghai Municipality (20Y11902000, 21ZR1411700); Shanghai Municipal Health Commission (201940143).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.22927